News:Alfa Study
Read the latest news about Alfa Study, the research platform at the Barcelonaβeta Brain Research Center (BBRC) to identify early pathophysicological characteristics of Alzheimer's disease to develop prevention strategies.
European researchers improve the sensitivity to detect the early stages of Alzheimer's disease
A team of researchers from the AMYPAD consortium, led at BBRC, showed that the visual assessment used in clinical practice to evaluate amyloid PET images is sensitive to detecting the earliest stages of Alzheimer’s disease, and suggests a method to classify the extent of the pathology in the brain.
Visits to the new study on the relationship between insomnia and Alzheimer's begin
200 participants from the Alfa + study will participate in Alfa Sleep
BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease
An international team of researchers, led at the BBRC, has discovered that a series of biomarkers recently described to detect the most advanced phase of Alzheimer's can also detect the preclinical phase of the disease in the cerebrospinal fluid and plasma.
Avalanche of data against Alzheimer's
The digitization of the data collected in our studies allows us to accelerate our research, improve its integrity and make it available to researchers around the world.
Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease
The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor
BBRC presents more than 20 studies at the Alzheimer's Association International Conference 2020
The most prominent congress dedicated to Alzheimer's research has been held completely virtual
Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women
The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy
BBRC researchers explain how their projects have progressed during the lockdown
The COVID-19 pandemic has not stopped the scientific activity of the Alzheimer’s Prevention Program
The BBRC resumes the visits of the participants to the center
Visits have been suspended for 3 months due to the COVID-19 pandemic, and have resumed with maximum security measures
